SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

30 May 2023 Evaluate
The sales for the March 2023 quarter moved down to Rs. 1003.17 millions as compared to Rs. 1065.53 millions during the year-ago period.The Net Profit of the company registered a slight decline of -13.67% to Rs. 126.95  millions from Rs. 147.06 millions.Operating profit for the quarter ended March 2023 decreased to 177.98 millions as compared to 215.13 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 1003.17 1065.53 -5.85 3796.36 4058.42 -6.46 3796.36 4058.42 -6.46
Other Income 48.19 51.60 -6.61 145.42 153.83 -5.47 145.42 153.83 -5.47
PBIDT 177.98 215.13 -17.27 589.34 948.56 -37.87 589.34 948.56 -37.87
Interest 0.17 3.01 -94.35 0.77 4.85 -84.12 0.77 4.85 -84.12
PBDT 177.81 212.12 -16.17 588.57 943.71 -37.63 588.57 943.71 -37.63
Depreciation 13.10 11.93 9.81 52.12 37.95 37.34 52.12 37.95 37.34
PBT 164.71 200.19 -17.72 536.45 905.76 -40.77 536.45 905.76 -40.77
TAX 37.76 53.13 -28.93 138.11 233.88 -40.95 138.11 233.88 -40.95
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 126.95 147.06 -13.67 398.34 671.88 -40.71 398.34 671.88 -40.71
Equity 29.23 29.23 0.00 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 17.74 20.19 -12.13 15.52 23.37 -33.58 15.52 23.37 -33.58

Amrutanjan Healthcar Share Price

575.55 -2.45 (-0.42%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×